Sign In

Key Populations.

HIV Question Bank

HIV in Sexual and Gender Minority PopulationsQuestion 6/10

Questions in Topic

A 39-year-old transgender woman with HIV presents to clinic for follow-up HIV care and gender-affirming care. They do not have any medical problems other than HIV. They have taken estradiol patches for about 1 year and have experienced moderate feminizing effects but have not yet achieved the desired physical effects. The plan is to start taking antiandrogen therapy with spironolactone.

Which one of the following are two common potential side effects with spironolactone?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 27th, 2023

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.